Meetodi tõendite kirje
EORTC QLQ-C30
The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.
Allikakirje
Tsiteeringud kopeeritud meetodi allikakirjest sõna-sõnalt. Nendest ei saa järeldada väidete tasemel kinnitust.
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30
Taksonoomiline meetodikirje · process-pipeline / health-outcomes
- Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. · DOI 10.1093/jnci/85.5.365
- Fayers, P. M., & Bottomley, A. (2001). Quality of life research within the EORTC-the EORTC QLQ-C30. European Journal of Cancer, 38(4), 427-431. · DOI 10.1016/s0959-8049(01)00448-8
- Cella, D. (1998). The Functional Assessment of Cancer Therapy Scale: Development and validation. Journal of Clin Oncol, 11(3), 570-579. · URL
Kureeritud väited
Väited on salvestatud tõendite registrisse, igal oma hinnanguga.
Kureeritud väiteid veel pole
See vaade ei loo väite hinnangut, kui registris seda pole.
Seotud meetodid
Genereeritud meetodigraafist ja kuvatud masina soovitatud seostena – väiteid ei järeldata.